Cargando…

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial

BACKGROUND: Recently, a new coronavirus spreads rapidly throughout the countries and resulted in a worldwide epidemic. Interferons have direct antiviral and immunomodulatory effects. Antiviral effects may include inhibition of viral replication, protein synthesis, virus maturation, or virus release...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dastan, Farzaneh, Nadji, Seyed Alireza, Saffaei, Ali, Marjani, Majid, Moniri, Afshin, Jamaati, Hamidreza, Hashemian, Seyed MohammadReza, Baghaei, Parvaneh, Abedini, Atefeh, Varahram, Mohammad, Yousefian, Sahar, Tabarsi, Payam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275997/ https://www.ncbi.nlm.nih.gov/pubmed/32544867 http://dx.doi.org/10.1016/j.intimp.2020.106688

Ejemplares similares

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital
por: Jamaati, Hamidreza, et al.
Publicado: (2018)

Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
por: Baghaei, Parvaneh, et al.
Publicado: (2021)

Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form
por: Tabarsi, Payam, et al.
Publicado: (2021)

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021)

Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
por: Barati, Saghar, et al.
Publicado: (2021)

Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infection
por: Tabarsi, Payam, et al.
Publicado: (2011)

Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran
por: Baghaei, Parvaneh, et al.
Publicado: (2020)

Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
por: Jamaati, Hamidreza, et al.
Publicado: (2021)

Evaluations of Factors Affecting of Short-and Long-Time of Occurrence of Disease Relapse in Patients with Tuberculosis Using Parametric Mixture Cure Model: A Cohort Study
por: Kazempour-Dizaji, Mehdi, et al.
Publicado: (2022)

Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021)

A 60 Year-Old Man with AIDS and Pneumonia
por: Tabarsi, Payam, et al.
Publicado: (2013)

Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Enterovirus-Human Rhinovirus as a Leading Cause of ARDS in a Liver Transplant Recipient
por: Yousefi, Meysam, et al.
Publicado: (2019)

NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals
por: Marjani, Majid, et al.
Publicado: (2020)

Health Care Associated Middle East Respiratory Syndrome (MERS): A Case from Iran
por: Moniri, Afshin, et al.
Publicado: (2015)

Tuberculosis in Solid Organ Transplantation
por: Alizadeh, Afshin Mohammad, et al.
Publicado: (2016)

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2023)

A 26 Year-Old Woman with AIDS and Pneumonia
por: Yousefzadeh, Amir, et al.
Publicado: (2013)

Etiology of Respiratory Complications among Iranian HIV Infected Patients
por: Marjani, Majid, et al.
Publicado: (2019)

COVID-19 in Iran: A model for Crisis Management and Current Experience
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

NRITLD Protocol for the Management of Outpatient Cases of COVID-19
por: Rezaei, Mitra, et al.
Publicado: (2021)

H1N1 Influenza Patient Saved by Extracorporeal Membrane Oxygenation: First Report from Iran
por: Jahangirifard, Alireza, et al.
Publicado: (2016)

Disseminated Kaposi's Sarcoma with the Involvement of Penis in the Setting of HIV Infection
por: Farshidpour, Maham, et al.
Publicado: (2015)

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2021)

Secondary infection and clinical aspects after pandemic swine–origin influenza a (H1N1) admission in an Iranian critical care unite
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2014)

Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis
por: Yousefian, Sahar, et al.
Publicado: (2021)

Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Efficacy of Early Prone Positioning Combined with Noninvasive Ventilation in COVID-19
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2021)

Bronchial Angioembolization for Management of Hemoptysis Due to Pulmonary Tuberculosis
por: Seyyedi, Seyed Reza, et al.
Publicado: (2021)

Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran
por: Moradi, Ahmadreza, et al.
Publicado: (2011)

National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19
por: Mirenayat, Maryam Sadat, et al.
Publicado: (2022)

Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
por: Malekzadeh, Reza, et al.
Publicado: (2020)

Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
por: Dalil Roofchayee, Neda, et al.
Publicado: (2021)

Diabetes mellitus and tuberculosis facts and controversies
por: Baghaei, Parvaneh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ssaq374jig8v065vbm08gr0m24